logo
Former Black Fern Cheryl Waaka battles stage 4 bowel cancer

Former Black Fern Cheryl Waaka battles stage 4 bowel cancer

NZ Herald24-07-2025
'I got my brother to get me to the GP in Kaikohe. Ambulance to Kawakawa. Ambulance to Whangārei and then that night broke the news that I have a tumour in my bowel and I need to have emergency surgery.
'I suppose I'm very lucky to my surgeon. He got the tumour, but unfortunately, it spread to my liver.'
In March, Health Minister Simeon Brown announced the National Bowel Screening Age would be lowered for all New Zealanders from 60 to 58, a step he said would save hundreds of lives.
The 'redirected' funding was previously set aside for a pilot programme that allowed Māori and Pacific people to access bowel cancer screening starting at age 50.
While Health Minister Simeon Brown said the age of eligibility for free bowel screening is projected to prevent an additional 771 bowel cancers and an additional 566 bowel cancer deaths over the next 25 years, advocates are calling the move 'institutionalised racism' as half of bowel cancers in Māori occur before the age of 60.
Waaka, who is up to date on all her health checks, said if the screening age were lowered to 50, her diagnosis would not have been stage 4.
'If it didn't happen now, would [the tumour] have been still sitting there, and by the time I got to 58, if I got to 58, it might have been too late.
'You look at me, strong, fit, healthy. It can happen to anyone. And I don't want it to happen to anyone.'
And the effect ripples to her whānau, she recalled the moment she had to break the news to her two children.
'I wouldn't like to wish that on anybody. Just myself to be told, and then to actually tell the kids.
'I was trying to hold myself to be strong, as we do as wāhine. So that was one of the hardest moments of my life. I wouldn't wish that.'
Calls grow to lower bowel cancer screening age to 45, as early-onset rates rise by 26% per decade. Photo / Getty Images
The rates of early onset have risen by 26% per decade on average over the past 20 years, according to University of Otago researcher Dr Oliver Waddell.
Researchers and Māori health practitioners have called for the age to be lowered to 45, as it is in many other countries.
'If we had [earlier] screening, I most probably wouldn't be costing the country money,' Waaka said.
'That's how I'm looking at it. If I was able to get screened at a younger age, you just imagine how much money this Government will be saving in health costs.'
Bowel cancer treatment costs depended on when it was found – stage 1 being the cheapest and stage 4 is the most expensive.
For Waaka, her bowel cancer has got into her liver, and aside from rounds of chemotherapy, the non-funded drug she needs comes at a cost of $30,000.
To start her first round of treatment on August 11, she is having to fundraise to survive. But Waaka said it's a big ask to turn to the community for funds.
'Life is hard, people are struggling, and for me, I feel like I'm taken from the whānau.
'And everyone said, you know, you've given so much, it's our time, but deep inside you know everyone's struggling to survive out there, and I'm just so grateful that people are willing to help me to survive and for me to fight this fight... which I'm going to do.'
She wants her off-the-field legacy to be remembered as much as her on-the-field career.
'I'm never one to ask for help, but I'm always giving. So for me, my legacy will be that I've given everything that I can, and hope I've just left something that will remind people of me.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Advertising unapproved medicines not legal, despite government claim
Advertising unapproved medicines not legal, despite government claim

RNZ News

time5 hours ago

  • RNZ News

Advertising unapproved medicines not legal, despite government claim

In a statement, Minister for Regulation David Seymour said the restriction on advertising new medicines at medical conferences "is being removed". Photo: RNZ / Mark Papalii Despite a government announcement suggesting it has lifted the ban on advertising unapproved medicines, it remains a criminal offence, warn legal experts. In a joint media release with Health Minister Simeon Brown, Minister for Regulation David Seymour welcomed "confirmation" of two major medical conferences in New Zealand next year, following the rule change to allow advertising of unapproved medicines at trade shows. The Ministry for Regulation had found the "overly cautious approach" was out of step with other recognised jurisdictions, and the government "acted fast to fix it", Seymour said. However, leading intellectual property lawyer Paul Johns - head of litigation for Pearce IP - cautioned the law had not yet changed. "If I were the organiser of these conferences and had seen those media releases, I would be making sure that my sponsors were aware that in fact the law has not changed and any medicines they want to advertise ought to be approved, because the consequences are criminal - there are fines and even imprisonment. "I don't think you would get that far, but they're there." Parliament was currently considering some amendments to the Medicines Act (to enable faster approval of drugs and widen powers for nurse prescribers) but there was nothing to do with advertising, he said. "It's still possible that the government could submit an amendment paper and put this advertising thing in there as well, but they haven't. So they appear to have a policy but they've done nothing about it in terms of legislation." The "great irony" was that under the Therapeutic Products Act - which was repealed by the current administration - the government could have simply introduced new regulations allowing such advertising, Johns noted. "But now they need to amend the Medicines Act." Others have pointed out that medical conferences were planned years in advance, so the new policy could not have been the deciding factor for next year's bookings. In a written response to RNZ's questions, Minister Seymour said the restriction on advertising new medicines at medical conferences "is being removed". "Ending New Zealand's prohibition on advertising medicines at medical conferences and trade shows has sent a message that New Zealand is open for business. That's exactly what medical conference organisers needed to hear, with two already confirmed for 2026." Medicines New Zealand chief executive Dr Graeme Jarvis said New Zealand had been missing out on conferences worth up to $90 million a year because it was impossible to run trade shows alongside them. "So you're actually losing out on not only the income you would get from running the conference and trade show here, but also the tourism spend as well." Clinicians had also been missing out. "Doctors here aren't getting exposed to all of the latest and greatest in terms of conferences, scientific exchange, the information and updates on all sorts of things." However, Auckland University associate professor of psychological medicine David Menkes said it was "misleading" to suggest doctors did not already have access to the latest information about new treatments. "But usually that information comes not from a company rep, it will come from an expert who's presenting as a colleague, rather than as an exhibitor or a sponsor of a conference." The academic psychiatrist said doctors liked to "believe they can't be swayed by corporate largesse" - but studies showed they were not immune. "That's why academic journals require peer review and disclosure of interests." Menkes is a long-time critic of New Zealand's permissive marketing regime : it is the only OECD country - apart from the United States - to allow direct-to-consumer advertising of medicines. Further loosening of the rules could compound the risk of over-prescribing, he said. "You don't want to be held up by red tape and bureaucracy, right? But you also want to have checks and balances in place. "I'm afraid this new policy doesn't have adequate checks and balances against overt promotional behaviour by vested interests." Seymour's office was unable to say when the government was planning to turn the policy into something Parliament could consider.

Letters: We shouldn't rush NCEA education reforms
Letters: We shouldn't rush NCEA education reforms

NZ Herald

time6 hours ago

  • NZ Herald

Letters: We shouldn't rush NCEA education reforms

It seems that this discussion is only just getting started, and if the Government truly wants a better system, it must listen to all those affected, not just industry leaders. If we really want a better system, proper consultation is needed, not yet another flawed scheme for teachers and students to grapple with. Vivien Fergusson, Mt Eden. Putting faith in AI After listening to Erica Stanford: AI marking will save money clearly but, having been on a marking panel, teachers learn valuable skills by marking that cannot be learned any other way. Also, student misconceptions abound. AI marking will save teachers from the internal marking. So what do they have left? Mock exams and homework? Learning is the key now, not understanding. One just needs to be able to say the right phrase. After all, AI has to mark it. I suppose the devil is in the fine print. Looks like we need to start teaching our grandchildren times tables again. It is as if we are back in the 1990s: Academic and non-academic pupils. Bright and dumb. The neurodiverse have just been sold out? We need to climb up the international rankings just to look good - a political stunt. Steve Russell, Hillcrest. Humans and the health system In 1999, a landmark report on patient safety in the American healthcare system was published. Its abbreviated title was 'To Err is Human'. The burden of that report was that human error occurs throughout the healthcare system and has patient safety consequences. The answer is not to blame the humans involved but to design a system that makes such errors less likely. A case in point is the recent instance reported in the Herald of a series of errors in the dispensing of the adult dosage of a medication to a baby. It might seem surprising that this could happen passing through the hands of three different people, but one wonders about the underlying system. In a properly designed electronic system for prescribing and dispensing medications, an entry of an adult dosage against a baby's identification should automatically generate a red flag. This would be a fail-safe. We should be paying more attention to enhancing the digital capabilities of our health system with inbuilt checks to make such instances of human error less likely. Peter Davis, Emeritus Professor, University of Auckland. Milk it for all it's worth A spoof announcement from the Ministry of Crypto-Dairy Affairs (MoCDA): In response to spiralling global butter prices — and the unwavering Kiwi passion for innovation — we proudly unveil ButterCoin, New Zealand's first dairy-backed digital currency. Finally, a coin as smooth as our export spreads. Key features of ButterCoin: Temperature-Sensitive Risk Protocol: Market stability will now hinge entirely on keeping things chilled. Once the market curdles, spreading risk becomes as futile as warm toast. Powered by ByreChain: Our revolutionary blockchain — or 'cowchain' — technology tracks every pat of ButterCoin from pasture to portfolio. Moo-ve over Bitcoin. Trading floor renamed The Churn: Investors will churn out profits daily, provided they don't get skimmed in the process. Elite trader upgrade – CreamCoin: High-volume dairy tycoons will be granted CreamCoin status, giving them exclusive access to the VIP Milking Lounge and first dibs on pasturefront NFTs. MoCDA Statement: 'This currency isn't just dairy-driven — it's full-fat financial futurism. Finally, a way to milk economic volatility for every drop.' Coming soon: Our launch event, Crypto & Cows, featuring live blockchain branding and a butter sculpture of Satoshi Nakamoo-to. Ready to churn your future into riches? Let's whip this market! Paul Coyle, Browns Bay. Names and passports In regards to the editorial last week (July 30) and the name on our passports, the passport is a legal document. 'Aotearoa' is not yet officially or legally a name for New Zealand. Therefore, it should not have the prominent position. The country's official name must take precedence. This is not to say that 'Aotearoa' should not be on the cover. Maybe we could have 'Nu Turani' on the passport, as this was the name used in the Māori version of the Treaty of Waitangi, or Nu Tīreni, which was used in the Declaration of Independence in 1835. Ian McGovern, Kerikeri.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store